(February 2, 2018, 2:35 PM EST) -- NEW YORK — Software developer Doctor Evidence LLC (DRE) failed to show that science, technical and medical information provider Elsevier Inc., a company with which it engaged in a professional services agreement (PSA), misappropriated DRE’s trade secrets to develop its own competing software program because DRE failed to plead what trade secret information was allegedly misappropriated, a federal judge in New York ruled Jan. 23 in granting Elsevier’s motion to dismiss certain of DRE’s counterclaims (Elsevier Inc. v. Doctor Evidence LLC, No. 17-5540, S.D. N.Y., 2018 U.S. Dist. LEXIS 10730)....